The LKB1 serine/threonine kinase is a tumour suppressor responsible for the inherited familial cancer disorder Peutz-Jeghers syndrome and is inactivated in a large percentage of human lung cancers. LKB1 acts a master kinase, directly phosphorylating and activating a family of 14 AMPK (AMP-activated protein kinase)-related kinases which control cell metabolism, cell growth and cell polarity. In this issue of the Biochemical Journal, Hardie and colleagues discover an alternative splice form of LKB1 that alters the C-terminus of the protein containing a few known sites of post-translational regulation. Although widely expressed, the short isoform (LKB1 s ) is the sole splice isoform expressed in testes, and its expression peaks at the time of spermatid maturation. Male mice lacking the LKB1 s isoform have dramatic defects in spermatozoa, resulting in sterility.
How the cell reprogrammes its metabolism and cell growth/cell fate decisions under conditions of low nutrients is a highly conserved process, which in all eukaryotes involves an orthologue of AMPK (AMP-activated protein kinase). Across species, AMPK orthologues are activated under conditions when intracellular ATP levels fall, such as when nutrients are limited [1] . Two molecular events are thought to control AMPK activation in most species studied to date: AMP binding to CBS (cystathionine β-synthase) nucleotide-binding domains in the AMPK regulatory γ subunit, and a required phosphorylation event in the activationloop threonine of the AMPK α subunit (Thr 172 in human AMPK). Convergent approaches from a number of laboratories in 2003 revealed that the kinase responsible for phosphorylating Thr 172 of AMPK under low ATP conditions is encoded in metazoans by the LKB1/STK11 serine/threonine kinase and its orthologues. Subsequent studies by Alessi and colleagues [2] revealed that LKB1 is a master upstream kinase directly phosphorylating the activation-loop threonine of 12 additional kinases in the AMPK family, including the Par-1/MARK (microtubule affinityregulating kinase) family of kinases. These had been genetically linked to LKB1 previously in a screen for genes required for embryonic patterning and polarity in Caenorhabditis elegans [2a] , a relationship also observed in Drosophila embryogenesis [8] (see Figure 1) .
Like AMPK itself, LKB1 is part of a heterotrimeric complex with two associated subunits, here a STE20-like pseudokinase named STRAD (Ste20-related adaptor) and a third protein named MO25 (mouse protein 25) [3] . These proteins are well-conserved throughout metazoans [4] , although while Mo25 orthologues have been clearly identified in fission and budding yeast, it is unclear whether they regulate LKB1 or AMPK orthologues. Importantly, in mammalian cells LKB1 kinase does not appear to be regulated in response to stress stimuli as measured by IP-kinase assays from a large number of groups, even though a number of post-translational modifications, including phosphorylation, acetylation and farnesylation, have been documented [3, 5, 6] . To date, no specific function has been attributed to the phosphorylation events on LKB1, although non-phosphorylatable alleles at several sites appear to behave similarly to kinase-inactive mutants in some assays [7] [8] [9] . Consistently with the LKB1 complex being constitutively active, the heterotrimeric LKB1-STRAD-MO25 complex purified from bacteria is active [10] , and increased phosphorylation of Thr 172 of AMPK in response to cellular stress appears to be mediated by suppression of phosphatase activity rather than induction of LKB1 kinase activity [11, 12] . Further support is provided by the fact that all of the other AMPK-related kinases examined so far appear to be constitutively phosphorylated on their activation-loop threonine residues, except in cells deficient in LKB1 [2] . Nonetheless, the mere existence of 14 downstream substrates for LKB1 that demonstrate varied subcellular locations suggests possible regulation through relocalization of LKB1-STRAD-MO25 complexes. This idea is reinforced by the finding that overexpression of the STRAD subunit results in cytoplasmic redistribution of LKB1, an effect that was recently shown to result from to altered interaction with the Crm1 nuclear import machinery [13] .
In addition to these potential regulatory mechanisms, during their biochemical identification of LKB1 as the major AMPKK (AMPK kinase) in rat liver, Hardie and colleagues noted a band with altered mobility that reacts with the LKB1 antibody in Western blots. This species is also stoichiometrically precipitated in the LKB1 immunoprecipitates, suggesting an LKB1 splice form [14] . In this issue of the Biochemical Journal, these authors describe the discovery of an alternative splice form of LKB1, which alters the final coding exon [15] . Existing cDNAs in the database indicated the existence of an alternative exon 9A. Messages including exon 9A lack exon 9B, resulting in a shorter polypeptide which also lacked a well-established and highly conserved PKA (protein kinase A)/RSK (ribosomal S6 kinase) phosphorylation site and farnesylation site at the very C-terminus of the originally defined 'long' isoform of LKB1 (LKB1 l ; see Figure 1 ). The authors created antibodies recognizing isoformspecific peptides and, combining these tools with the immunoprecipitation of both endogenous isoforms using an antibody directed against the N-terminus, they examined their tissue distribution. Strikingly, whereas most rodent tissues examined express a mixture of both isoforms, the LKB1 s isoform is the predominant isoform expressed in both testes and spleen [15] . The authors next examined whether the short LKB1 isoform displays altered function relative to the standard long isoform in a number of assays. First, they examined whether the short isoform is altered in its ability to activate AMPK, or several of the AMPK-related kinases. The authors took advantage of the fact that HeLa cells lack LKB1 to introduce each isoform in the absence of the other. No significant difference was observed, although in vitro kinase assays using purified recombinant AMPKα1 or the BRSK (brain-specific kinase)/SAD kinases as substrates both revealed increased catalytic activity of the LKB1 s isoform. Strikingly, despite lacking the farnesylation site and Cterminal phosphorylation site, no difference was observed for the subcellular localization of each isoform in HeLa cells. Further studies will be required to determine whether, in some cell types, there may be a differential localization for either isoform in response to specific stimuli, particularly those that result in increased phosphorylation of Ser 428 or farnesylation of Cys 430 . To directly investigate a requirement for the LKB1 s isoform, the authors took advantage of a genetically engineered mouse bearing a conditional floxed allele of LKB1 in which the middle five exons were replaced by a cDNA encoding only the long isoform. Thus, when homozygous for the floxed allele, these animals completely lack the short isoform for LKB1 but retain expression of the long isoform. Male mice homozygous for the floxed allele are sterile, which, given the authors' observation that the short isoform is highly expressed in testes, hinted that LKB1 s may play a role in spermatogenesis. A detailed time course of LKB1 s expression in testes revealed it to be dramatically up-regulated; coincident with the first appearance of mature haploid spermatids. Fractionation of the various cell populations in the testes suggested expression in developing germ cells after meiosis. Histological examination of mice lacking LKB1 s revealed a nearcomplete absence of mature spermatozoa. Isolated spermatids from LKB1 s -deficient mice were completely non-motile and displayed abnormal acrosome morphology, as visualized by scanning electron microscopy, perhaps suggestive of a cellpolarity defect.
Much future work will be needed to define which of the 14 LKB1-dependent kinases are important for sperm maturation. The Par-1/MARK kinase subfamily has well-established roles in cell polarity, and the related SAD kinases have been shown to be critical for cell polarity in neurons, where they are most highly expressed [3, 9, 16] . Moreover, AMPK has been shown to play a role in cell polarity in Drosophila and some mammalian cell types, so it could be involved in the LKB1 s -deficient phenotype [17] . Strikingly, another of the 14 LKB1-dependent kinases, SNRK [SNF1 (sucrose non-fermenting protein 1)-related kinase], is only expressed appreciably in the testes [18] , making it an excellent candidate to be mediating some the effects of the LKB1 s isoform in this tissue.
Several intriguing questions remain. First, the prominent expression of LKB1 s in spleen warrants a closer examination of whether specific haemopoetic lineage(s) predominantly express this isoform, and whether subtle immunological defects may exist that are revealed in response to specific immune challenges. Polarization is also critical in T-cell activation and stem cell differentiation, so it would be interesting to examine whether LKB1 s , or simply LKB1 in general, plays a role in this process. Another question raised by these findings is the nature of the signal leading to the dramatic up-regulation of LKB1 s protein at the time of sperm maturation.
Finally, even though this is the first report of an alternative splicing event for LKB1, other pathway components are known to be alternatively spliced. For example, AMPK γ subunits 2 and 3 each encode two different splice isoforms [1] , and the key LKB1 regulatory subunits STRADα and STRADβ have three annotated splice isoforms in Uniprot. A recent study revealing 12 distinct splice isoforms of STRADα [19] has opened a 'Pandora's box' of potential complexity. As more is discovered about the regulation of LKB1 and its subunits by alternative splicing and post-translational modification, the environmental signals that control formation of the LKB1 heterotrimeric complex and direct it towards subsets of its downstream kinases controlling cell proliferation, glucose metabolism and cell polarity will be better illuminated. For now, we can add spermatogenesis to the list of physiological processes for which LKB1 is required in mammals, alongside suppression of tumorigenesis, control of cell polarity, and control of glucose metabolism.
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